172 related articles for article (PubMed ID: 17901830)
41. Evolving paradigms in chemotherapy-induced nausea and vomiting and symptom management for the breast cancer patient.
Biedrzycki BA
ONS Connect; 2007; 22(8 Suppl):9-10. PubMed ID: 17824543
[No Abstract] [Full Text] [Related]
42. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
[TBL] [Abstract][Full Text] [Related]
43. Physical activity and breast cancer mortality.
Harris SR
Eur J Oncol Nurs; 2009 Sep; 13(4):233-4. PubMed ID: 19656724
[No Abstract] [Full Text] [Related]
44. [Chemotherapy of glioblastomas].
Taillibert S
Soins; 2009 Mar; (733):38-9. PubMed ID: 19366001
[No Abstract] [Full Text] [Related]
45. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
Dixon JM
Expert Rev Anticancer Ther; 2008 Mar; 8(3):453-63. PubMed ID: 18366292
[TBL] [Abstract][Full Text] [Related]
46. The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.
Poole R; Paridaens R
Curr Opin Oncol; 2007 Nov; 19(6):564-72. PubMed ID: 17906453
[TBL] [Abstract][Full Text] [Related]
47. Use of hair dyes following chemotherapy.
Decker GM
Clin J Oncol Nurs; 2004 Feb; 8(1):89-91. PubMed ID: 14983770
[No Abstract] [Full Text] [Related]
48. Tolerance of adjuvant letrozole outside of clinical trials.
Fontaine C; Meulemans A; Huizing M; Collen C; Kaufman L; De Mey J; Bourgain C; Verfaillie G; Lamote J; Sacre R; Schallier D; Neyns B; Vermorken J; De Grève J
Breast; 2008 Aug; 17(4):376-81. PubMed ID: 18455395
[TBL] [Abstract][Full Text] [Related]
49. Adjuvant chemotherapy in cancer.
Block JB; Isacoff WH
Semin Oncol; 1977 Mar; 4(1):109-15. PubMed ID: 265100
[No Abstract] [Full Text] [Related]
50. [Assessment of oncologic risk of breast reconstruction simultaneous with surgery for breast cancer].
Portnoĭ SM; Blokhin SN; Arslanov KhS; Laktionov KP; Balakireva GV; Akhmetov MSh
Vopr Onkol; 2008; 54(6):720-3. PubMed ID: 19241846
[TBL] [Abstract][Full Text] [Related]
51. The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
Winer E
Clin Adv Hematol Oncol; 2008 Aug; 6(8):573-4. PubMed ID: 18820598
[No Abstract] [Full Text] [Related]
52. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
[TBL] [Abstract][Full Text] [Related]
53. Practice patterns in colorectal cancer: a panel discussion.
Becze E
ONS Connect; 2007; 22(8 Suppl):51-2. PubMed ID: 17824564
[No Abstract] [Full Text] [Related]
54. Oral chemotherapy medications: the need for a nurse's touch.
Winkeljohn DL
Clin J Oncol Nurs; 2007 Dec; 11(6):793-6. PubMed ID: 18063536
[TBL] [Abstract][Full Text] [Related]
55. Combined adjuvant chemotherapy with radical mastectomy for carcinoma of the breast.
Schiebel HM
N C Med J; 1966 Feb; 27(2):57-62. PubMed ID: 5217039
[No Abstract] [Full Text] [Related]
56. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
[TBL] [Abstract][Full Text] [Related]
57. [Postoperative chemotherapy for breast neoplasms].
Watanabe T
Nihon Rinsho; 2007 Jun; 65 Suppl 6():511-5. PubMed ID: 17682203
[No Abstract] [Full Text] [Related]
58. In regard to post mastectomy radiotherapy.
Monsour PD
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):686-7; author reply 687-8. PubMed ID: 15380609
[No Abstract] [Full Text] [Related]
59. Managing the complex journey of renal cell carcinoma.
Amen K
ONS Connect; 2007; 22(8 Suppl):53-4. PubMed ID: 17824565
[No Abstract] [Full Text] [Related]
60. Advances in chemotherapy options for metastatic breast cancer: introduction of epothilones.
McGee L
ONS Connect; 2007; 22(8 Suppl):29-30. PubMed ID: 17824553
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
